Back
FT Nasdaq Artfcl Intllgnc and Rbtc ETF Vs. Disc Medicine Industry Stock Comparison
Buy
66
ROBT
FT Nasdaq Artfcl Intllgnc and Rbtc ETF
Last Price:
44.00
Seasonality Move:
12.47%
Buy
81
IRON
Disc Medicine
Last Price:
58.11
Seasonality Move:
9.89%
Buy
66
FT Nasdaq Artfcl Intllgnc and Rbtc ETF (ROBT)
is a Buy
Is FT Nasdaq Artfcl Intllgnc and Rbtc ETF a Buy, Sell or Hold?
- The current FT Nasdaq Artfcl Intllgnc and Rbtc ETF [ROBT] share price is $43.75. The Score for ROBT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- ROBT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
81
Disc Medicine (IRON)
is a Buy
Is Disc Medicine a Buy, Sell or Hold?
- The current Disc Medicine [IRON] share price is $58.22. The Score for IRON is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- IRON is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ROBT Stock Price Chart
What is FT Nasdaq Artfcl Intllgnc and Rbtc ETF's stock price today?
-
The FT Nasdaq Artfcl Intllgnc and Rbtc ETF share price today is $43.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ROBT is experiencing selling pressure, which indicates risk of future bearish movement.
IRON Stock Price Chart
What is Disc Medicine's stock price today?
-
The Disc Medicine share price today is $58.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IRON is experiencing slight selling pressure.
ROBT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 51.86 | Buy |
| Chaikin Money Flow: | -17965 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.25 - 44.21) | Buy |
| Bollinger Bands (100): | (41.19 - 43.91) | Buy |
IRON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 72.94 | Buy |
| Chaikin Money Flow: | -313660 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.74 - 51.42) | Buy |
| Bollinger Bands (100): | (44.12 - 49.9) | Buy |
ROBT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.77 | Sell |
| 20-day SMA: | 43.85 | Sell |
| 50-day SMA: | 42.97 | Buy |
| 200-day SMA: | 43.22 | Buy |
| 8-day EMA: | 43.76 | Sell |
| 20-day EMA: | 43.67 | Buy |
| 50-day EMA: | 43.19 | Buy |
| 200-day EMA: | 42.84 | Buy |
IRON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.49 | Buy |
| 20-day SMA: | 48.16 | Buy |
| 50-day SMA: | 48.73 | Buy |
| 200-day SMA: | 47.54 | Buy |
| 8-day EMA: | 49.13 | Buy |
| 20-day EMA: | 48.46 | Buy |
| 50-day EMA: | 48.01 | Buy |
| 200-day EMA: | 46.63 | Buy |
FT Nasdaq Artfcl Intllgnc and Rbtc ETF Earnings Growth & ROBT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Disc Medicine Earnings Growth & IRON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.16 per share, and a decrease next year of $0.57 per share.
FT Nasdaq Artfcl Intllgnc and Rbtc ETF Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Disc Medicine Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||